The US Food and Drug Administration has granted full approval towards Pﬁzer and BioNTech’s COVID-19 Vaccine on Monday. This approval comes as the ﬁrst COVID-19 vaccine to be fully approved by the FDA, and it hopes to spark conﬁdence in American citizens to get theirs. The mRNA vaccine had previously only been approved for emergency use by FDA back in December, with more than 204 million Pﬁzer shots being issued since then.
Pﬁzer and BioNTech had submitted their application for full approval since early May, sending in a Biologics License Application for their vaccine speciﬁcally for those ages 16 and up. FDA scientists had gone over “hundreds of thousands of pages” of vaccine data comprising 40,000 trial participants, concluding that Pﬁzer’s mRNA vaccine had met the FDA’s standards. FDA commissioner Janet Woodcock said in a press statement that, “While millions of people have already safely received COVID-19 vaccines, we recognize for some, the FDA approval of a vaccine may now instill additional conﬁdence to get vaccinated.” PFE shares ended up 2.48% on Monday and down 4.35% by the end of Friday.